Expertise in
3
conditions

Miguel A. Torralba

Toledo, CM, ES 
Expertise in
3
conditions
Toledo, CM, ES 

Overview

Miguel Torralba practices practicing medicine in Toledo, Spain.

Mr. Torralba is highly rated in 3 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis, Hepatitis B, and COVID-19.

He is actively involved in clinical research, co-authoring 81 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Toledo, CM, Spain
Other Locations
Guadalajara, CM, Spain
La Mancha Blanca, CN, Spain
Alcala De Henares, MD, Spain
Madrid, MD, Spain
Alcala Del Rio, AN, Spain
Zaragoza, AR, Spain
Castilla, MD, Spain
Spain
Barcelona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Extension Study in a Cohort of Adult Patients With SARS-CoV-2 Infection Requiring Hospital Admission and Received Treatment With Plitidepsin in the APLICOV-PC Study
Extension Study in a Cohort of Adult Patients With SARS-CoV-2 Infection Requiring Hospital Admission and Received Treatment With Plitidepsin in the APLICOV-PC Study
Enrollment Status: Completed
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Plitidepsin
Study Phase: Phase 1/Phase 2
Multicenter Retrospective Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
Multicenter Retrospective Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
Enrollment Status: Completed
Publish Date: February 05, 2020
View 1 Less Clinical Trial

81 Total Publications

Correction: Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy.
Correction: Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy.
Journal: PloS one
Published: July 24, 2026

Frequently Asked Questions about Miguel A. Torralba

Is Miguel A. Torralba a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Miguel A. Torralba is classified as an Advanced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Miguel A. Torralba participate in research or clinical trials?

Yes. Miguel A. Torralba has published 81 articles and abstracts on conditions like HIV/AIDS. You can view a list of Miguel A. Torralba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Torralba's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile